Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Net Cash Flow (2021 - 2025)

Historic Net Cash Flow for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to -$5.1 million.

  • MDxHealth's Net Cash Flow fell 11857.63% to -$5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$16.2 million, marking a year-over-year decrease of 17947.27%. This contributed to the annual value of -$11.0 million for FY2024, which is 117162.43% down from last year.
  • As of Q3 2025, MDxHealth's Net Cash Flow stood at -$5.1 million, which was down 11857.63% from -$33.2 million recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Net Cash Flow registered a high of $32.2 million during Q4 2021, and its lowest value of -$33.2 million during Q2 2025.
  • Moreover, its 5-year median value for Net Cash Flow was -$5.1 million (2025), whereas its average is $477705.9.
  • In the last 5 years, MDxHealth's Net Cash Flow skyrocketed by 70181.98% in 2024 and then crashed by 34743.87% in 2025.
  • Over the past 5 years, MDxHealth's Net Cash Flow (Quarter) stood at $32.2 million in 2021, then tumbled by 127.79% to -$8.9 million in 2022, then increased by 29.52% to -$6.3 million in 2023, then skyrocketed by 37.31% to -$4.0 million in 2024, then decreased by 28.99% to -$5.1 million in 2025.
  • Its last three reported values are -$5.1 million in Q3 2025, -$33.2 million for Q2 2025, and $26.1 million during Q1 2025.